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Abstract Post-infectious disease syndrome includes both
neurological and non-neurological disorders. However,
headache as an isolated or a presenting complaint of post-
infectious illness has not been well acknowledged in the
literature. In this retrospective observation, patients having
daily headache of more than 1 week and \4 weeks dura-
tion were included. We divided this group into patients
having headache with preceding history of febrile illness in
the recent past and patients without such history of febrile
illness. We compared clinical features and therapeutic
responses of various drugs between the groups. There were
no signiﬁcant differences in demographic features in these
groups. However, associated neck pain, nausea, photo-
phobia and meningeal signs were more prevalent in
patients having history of preceding infection. A relatively
lower proportion of subjects showed complete response to
drugs at 3 months in post-infectious group. Good responses
were noted to steroids in post-infectious group. In con-
clusion, a subset of patients with daily headache may be
because of post-infectious pathology and treatment in the
early stage may prevent it from becoming chronic. Large
prospective studies are required to conﬁrm these
observations.
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Introduction
Headaches attributed to infectious causes are important
secondary causes of headache. The ICHD-II divides
‘‘headache attributed to infection’’ into four categories: (1)
headache attributed to intracranial infection, (2) headache
attributed to systemic infection, (3) headache attributed to
HIV/AIDS, and (4) chronic post-infection headache [1].
A diagnosis of headache attributed to an infection usu-
ally becomes deﬁnite only when the headache resolves or
greatly improves after effective treatment or with sponta-
neous remission of the infection. When the intracranial
infection is effectively treated or when it remits sponta-
neously, but headache persists for more than 3 months, the
diagnosis of chronic post-infection headache is made.
There is only one subgroup of chronic post-infection
headache, chronic post-bacterial meningitis headache. In
this group, the headache is a direct continuation of head-
ache attributed to bacterial meningitis [2]. Viral meningitis
(aseptic meningitis) may also cause chronic post-infection
headache [2], and ICHD-II acknowledged this as post-non-
bacterial infection headache in the Appendix (A9.4.2) [1].
Besides these, infectious etiology has been suggested in a
subset of patients with NDPH, where infection is consid-
ered as a triggering factor for generation of headache [3].
ICHD-II describes (chronic) post-infection headache as
a direct continuation of headache attributed to bacterial
meningitis. However, post-infectious disorder is usually
described when symptoms and signs develop following
recovery from an infection elsewhere in the body [4].
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disorders [acute disseminated encephalomyelitis (ADEM),
chronic fatigue syndrome] may have headache as one of
the accompanying symptoms. However, headache as an
isolated or a presenting complaint of post-infectious illness
has not been well acknowledged in the literature. Recently,
a case series on post-infectious variant of NDPH has been
reported in which all nine patients had a history of febrile
illness before the onset of headache [5]. To look for the
spectrum of post-infectious headache, herein, we retro-
spectively studied the headache proﬁles where patients
reported history of febrile illness before the development of
headache.
Materials and methods
This study was conducted as a retrospective chart review of
patients seen in neurology department in our institute from
September 2008 to August 2010. The study did not require
approval by the local ethics committee as per the local
regulations for retrospective observations. The patients
havingdailyorneardailyheadacheformorethan1 weekand
\4 weeks duration, and with minimum follow-up of
3 monthsdurationwereincludedinthestudy.Afewpatients
were interviewed on telephone to complete the follow-up.
Thesepatientswerespeciﬁcallyreviewedforthepresenceof
febrile illness in the preceding 4 weeks before the onset of
headache. We divided the patients into two broad groups:
patients having headache with preceding history of febrile
illness in the recent past and patients without such history of
febrile illness. We compared clinical features and thera-
peutic responses of various drugs between the groups.
The headache duration of more than 1 week was
included to just rule out the possibility of an episode of
tension headache according to ICHD-2 criteria. The
headache duration of more than 4 weeks was excluded to
minimize recall bias for the presence of preceding illness.
The patients having headache since the onset of febrile
illness were excluded from the observation to rule out the
possibility of headache attributed to systemic infection,
chronic post-bacterial or non-bacterial infection headache
(ICHD-2: 9.2, 9.4, and A9.4.2). All these three headache
groups have headache with evidence of infections. Patients
having past history of headache in the last 1 year were also
excluded from the observation. The patients having history
suggestive of red ﬂags (as suggested by Goadsby and
Raskin [6]) were excluded from the observations. The
patientshavingabnormalneurologicalexaminations(except
for the presence of meningeal signs) were excluded.
The majority of patients were seen and examined by a
neurologist and further investigational studies, especially
neuroimaging and lumbar puncture were requested when
clinically indicated to exclude secondary etiologies. Man-
agement decisions were made at the discretion of the
treating physicians.
Results
Thirty-four patients having daily or near daily headache of
more than 1 week and\4 weeks duration were identiﬁed.
We classiﬁed these patients in two broad groups: patients
with and without history of febrile illness in last 4 weeks.
Twenty-three patients (68%) had a preceding febrile illness
before the onset of headache. Epidemiological and clinical
features of both groups were compared (Table 1). There
were no signiﬁcant differences in age, sex, and duration of
headache between the groups at the time of presentation.
The site of pain was also comparable in both the groups.
None of the differences were statistically signiﬁcant.
However, associated neck pain was more in group having
history of infection (61 vs. 36%). The quality of pain was
predominantly dull or pressing type, in both the groups in
about 75%. Most of the patients in both the groups had
mild to moderate intense headache. However, continuous
pain with or without ﬂuctuation was more common in post-
infectious headache (78 vs. 64%). Nausea, photophobia
and meningeal signs (neck rigidity, Kernig’s sign) were
more prevalent in patients having history of febrile illness.
All patients had headache on nearly daily basis at the time
of presentation. Fourteen patients (61%) in post-infectious
group and ﬁve patients (46%) in non-infectious group had
daily headache since the onset of pain. Headache became
continuous within 3 days of the onset in another ﬁve
patients (22%) of post-infectious group and two patients
(18%) of second group. Continuous head pain with not
much or minimal ﬂuctuation was the most common type of
headache pattern.
The details of preceding febrile illness and its relation
with headache have been summarized in Table 2. Only ﬁve
patients received deﬁnitive diagnoses during their febrile
illness (dengue 2 patients, H1N1-2 patients, salmonella
typhi 1 patient). Other 18 patients had non-speciﬁc infec-
tions. Most of them had upper respiratory tract infections
(rhinitis 8, pharyngitis 7). Three patients had a history
suggestive of gastrointestinal infections. In most of the
patients (21 out of 23), headache started within 3 weeks of
the cessation of febrile illness.
Provisional diagnoses, at the time of presentation, were
either probable chronic migraine or probable CTTH or
probable NDPH in all the patients.
Neuroimaging was essentially normal or was not casu-
ally related in both the groups. CSF examinations were
performed in all patients of both groups having meningeal
signs. CSF pleocytosis ([5 cells/mm) were noted in three
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123patients in post-infectious group (out of 9 in whom CSF
analysis was done) and in one patient (out of 3 patients) in
other group. CSF protein and glucose were within normal
limit.
All patients received medications. The drugs used and
treatment responses are summarized in Table 1. All patients
Table 2 Relation of infection with headache
Parameters Headache preceded
by infection (n = 23)
Type of illness
Speciﬁc illness
Dengue 2
H1N1 2
Salmonella typhi 1
Non speciﬁc
Rhinitis 8
Pharyngitis 7
Gastroenteritis 3
Time interval with headache onset (weeks)
\18
1–2 7
2–3 6
3–4 2
Table 1 Differences between headache preceded by infection and
headache with no prior history of recent infection
Parameters Headache
preceded by
infection
(n = 23)
Headache with
no prior history
of recent
infection
(n = 11)
Age (years) (mean, range) 32.5 ± 12.6,
17–55
34.8 ± 14.5
Sex (F:M) 12:11 6:05
Duration of headache (weeks)
1–2 10 (44%) 4 (36%)
2–3 7 (30%) 4 (36%)
3–4 6 (26%) 3 (27%)
Location of pain
Holocephalic 10 (44%) 5 (46%)
Parieto occipital 8 (35%) 3 (27%)
Fronto temporal 5 (22%) 3 (27%)
With neck pain 14 (61%) 4 (36%)
Quality of pain
Pressing 17 (74%) 8 (73%)
Throbbing 6 (26%) 3 (27%)
Variability of headache
Intermittent daily pain 5 (22%) 4 (36%)
Constant with no or little
ﬂuctuations
14 (61%) 6 (55%)
Constant with frequent
exacerbations
4 (17%) 1 (9%)
Severity
Mild to moderate 21 (91%) 9 (82%)
Severe 2 (9%) 2 (18%)
Associated symptoms and signs
Nausea 7 (30%) 2 (18%)
Photophobia 7 (30%) 2 (18%)
Phonophobia 2 (9%) 1 (9%)
Cranial autonomic feature 1 (4%) 0
Meningeal sign 9 (39%) 3 (27%)
Body pain 5 (22%) 2 (18%)
Neuroimaging
Normal 13/13 4/4
CSF examinations
Pleocytosis 3/9 0/3
Provisional diagnosis (at the time of presentation)
Probable migraine 8 4
Probable CTTH 11 6
Probable NDPH 4 1
Treatment
Dothiepin 12 6
Amitriptyline 4 5
Valproate 7 4
Propranolol 4 0
Leviteracetam 3 0
Table 1 continued
Parameters Headache
preceded by
infection
(n = 23)
Headache with
no prior history
of recent
infection
(n = 11)
Paracetamol 8 5
Naproxen 15 6
Indomethacin 5 1
Steroids 10 2
Follow-up and treatment response
At 3 months
Complete response 8 (35%) 6 (55%)
Marked response with episodic
headaches (1–5 attacks/week)
10 (43%) 4 (36%)
No or minimal response 5 (22%) 1 (9%)
Response to steroids
(at 3 months)
(10 patients) (2 patients)
Marked and immediate 4/10 (40%) 0/2
Moderate response 3/10 (30%) 1/2
Mild to no response 3/10 (30%) 1/2
Response to steroids (IV MPS)
(at 9 months)
(7 patients) (2 patients)
Marked and immediate 3/7 (42%) 0/2
Moderate response 2/7 (29%) 1/2
Mild to no response 2/7 (29%) 1/2
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123havefollow-upofminimum3 monthsdurations(asinclusion
criteria). The treatment response at 3 months of the onset of
symptoms was analyzed.
A relatively lower proportion of subjects showed com-
plete response at 3 months in post-infectious group as
compared to non infectious group (35 vs. 55%). Five
patients (22%) in post-infectious group and 1 patient (9%)
in other group showed minimal or no response at the end of
3 months of symptom onset, and now these patients ful-
ﬁlled the criteria of NDPH. Other patients, 10 patients
(43%) in post-infectious group and 4 (36%) in non-infec-
tious group, had mild to moderate improvement in head-
ache proﬁles.
Steroids were supplemented along with other drugs in a
few patients who did not show response to usual therapies.
None of the patients received steroids at the beginning of
the therapy. Oral steroids were added after 2–6 weeks of
usual therapies. 10 patients of post-infectious group and 2
in other group received steroids (mainly oral prednisolone,
1 mg/kg body wt) in the ﬁrst 3 months. Steroids were
given for 7 days to 2 weeks duration; four patients (40%)
in post-infectious group had a marked immediate effect
(within 2–4 days) to steroid. Another three patients showed
moderate effect to steroid. One patient (out of 2) in non-
infectious group showed moderate effect to prednisolone.
Fifteen patients (65%) in post-infectious group and ﬁve
patients (45%) in other group still had headache at the end
of 3 months. We were able to get follow-up of a few more
patients in both the groups (9 patients in ﬁrst group and 2
patients in second group) at the end of 9 months. Three
patients in post-infectious group and both patients of non
infectious group were almost symptom free. Another four
patients had marked improvement (1–4 attacks/month).
However, two patients in the post-infectious group still had
continuous headache (although with mild back ground pain
with reduced frequency of exacerbations).
Three of these nine post-infectious group patients had
received oral steroid during ﬁrst 3 months and had noted
steroids as effective drug, at least moderately effective for
a few weeks. These three patients and four more patients
received a pulse therapy of IV MPS for 3–5 days. The
response to steroids in these seven patients of post-infec-
tious group were: marked immediate effect (3 patients),
moderately effective (2 patients), and minimal response
(2 patients). One patient of the non-infectious group also
received IV MPS and this patient showed moderate
response to steroid.
Discussion
In this retrospective observation of continuous or near daily
headache of shorter duration (1–4 weeks), we speciﬁcally
looked for the presence of history of febrile illness in the
recent past (\4 weeks). Post-infectious disorders usually
start after an active infection [4]. The distinction of
infectious from post-infectious process is important as
infectious process depends on the continued presence of
viable microorganisms and should be treated with antimi-
crobial therapy, while post-infectious process ought to be
blocked by inhibition of the involved host process [4].
We compared patients with continuous headache of
shorter duration with history of recent infection in the past
to patients with similar type of headache, but without any
recent febrile illness. The demographic features of both
groups were substantially similar. Although there were no
statistically signiﬁcant differences between the groups, a
few striking differences between the groups were noted.
The post-infectious group was more likely to have asso-
ciated neck pain, body pain, nausea, photophobia, and
meningeal signs. The post-infectious group had more
continuous headache.
None of the patients fulﬁlled criteria of any primary
headache disorders. The patients having headache since the
onset of febrile illness were excluded from the observation
to rule out the possibility of headache attributed to intra-
cranial infections, headache attributed to systemic Infec-
tion, chronic post-bacterial or non-bacterial infection
headache, and aseptic meningitis (ICHD-2: 9.1, 9.2, 9.4,
A9.4.2 and 7.3.2). However, due to the presence of neck
pain, meningeal signs and pleocytosis, possibility of these
differential diagnoses cannot be ruled out completely,
especially headache attributed to lymphocytic meningitis
(9.1.2) and headache attributed to systemic infection (9.2).
However, lymphocytic meningitis because of direct
involvement of microorganisms seem to be less likely as
patients did not have fever (with headache) and general
feeling of illness. Headache attributed to lymphocytic
meningitis usually resolves within 1 week (notes of 9.1.2).
In our case series, all patients had headache duration of
more than 1 week (as inclusion criteria). In headache
attributed to systemic infection, headache develops during
the systemic infection and resolves within 72 h after
effective treatment of the infections. None of the patients
had these features. Another possibility in our patients is
headache attributed to aseptic (non-infectious) meningitis
(7.3.2). IHS recognizes ibuprofen, penicillin, trimethoprim
and others as causative factors for the generation of
headache attributed to aseptic (non-infectious) meningitis.
Few of our patients received these drugs in their febrile
episodes. However, possibility of this headache disorder is
less likely as patient had already left these drugs well
before the onset of headache.
The diagnosis of headaches is mostly clinical, according
to the criteria of the International Headache Society (IHS)
and such strict criteria are important for scientiﬁc reasons
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123(research purpose), but, in clinical practice, they seem to be
too restrictive, and we ﬁnd a large number of patients not
ﬁtting in any criteria. This problem is more in patients with
chronic daily headache (CDH). The literature is silent on
classifying sub-acute onset daily headaches. Sudden onset
daily headache is a characteristic of NDPH. Our most
patients had headache duration of 1–2 weeks (at the time of
presentation); 1–2 weeks duration was not sufﬁcient
enough to label this type of headache as NDPH. An episode
of headache may present up to 7 days in tension-type
headache (according to the IHS criteria). The prevalence of
TTH is far common in comparison to NDPH and other
headache disorders. Therefore, probable CTTH was the
most common provisional diagnosis in both groups. Prob-
able chronic migraine and probable NDPH were the other
two (differential) diagnoses. The treatment response at the
3 months was less favorable in post-infectious group. 65%
patients in post-infectious group and 45% in other group
still had continuous or intermittent headache at the
3 months and most of them fulﬁlled the criteria of CDH.
Neck pain is a common occurrence in patients with
CDH and it has been associated with poor outcome [7]. The
co-occurrence of headache and neck pain may be because
of common pathogenesis, a causal association, or a com-
mon confounding factor. However, the presence of men-
ingeal signs and pleocytosis in CSF in a few patients
indicate involvement of meninges, and both headache and
neck pain may be because of common pathogenesis
(meningeal involvement).
The presence of meningeal signs in patients with
recurrent or chronic headache has not been well explored in
the literature. We noted only one article in the literature
where signs of meningeal irritation were observed in
patients with CDH [8]. This observation was done in
children and adolescents, in which 97% children with
tension headache and 12% children with migraine showed
meningismus and the authors suggested that tension-type
headache is basically a secondary headache disorder and its
main clinical features is because of meningismus. The
authors suggested a possibility of mild sterile (possibly
autoimmune) inﬂammation of meninges because of pre-
ceding infection and minor trauma to head and/or back [8].
Meningeal sign in the form of neck stiffness (with nausea,
photophobia, phonophobia) was a common accompanying
features (50%) in Li and Rozen’s [9] case series of NDPH.
Post-infectious disease syndromes are immune-mediated
inﬂammatory diseases that include both neurological and
non-neurological disorders. However, headache as an iso-
lated or a presenting complaint of post-infectious illness
has not been well acknowledged in the literature. Recently,
a case series of post-infectious NDPH has been reported
where the onset of headache was preceded by an episode of
febrile illness [5]. Besides it, NDPH may start during a
febrile episode and may present for many years or even life
long. In Mack series of NDPH, 43% patients had onset of
their symptoms during an infection [3]. In Li and Rozen’s
[9] case series NDPH onset occurred in relation to an
infection or ﬂu-like illness in 30% cases. Serological evi-
dence of present or past viral infections has also been
demonstrated in high proportion in patients with NDPH
[10, 11].
Migraine can have an abrupt transition from episodic to
chronic form (transition may be abrupt, like onset of
NDPH). Mack [3] reported that such abrupt transition (in
children) is most commonly associated with febrile illness.
A few other authors have also demonstrated ﬂu-like illness/
sinusitis as risk factors for abrupt transition from episodic
to chronic daily headache disorders [12]. The exact path-
ophysiology of abrupt onset of NDPH and abrupt transition
of episodic headache to chronic daily headache has not
been explored. However, a close temporal relation with
febrile illness may suggest a possibility of post-infectious
process in daily or near daily headache disorders.
Favorable response to immunotherapy is one of the
indirect evidences to consider a disease as a post-infectious
disorder [4]. Most post-infectious disorders show a response
to steroids and other immunosuppressive drugs. The liter-
ature on the use of steroids in the treatment of headache
disorders is conﬂicting. Most studies are done on migraine
patients. The available data suggests that steroids may be
more useful in subjects with migraine lasting longer than
72 h [13]. A few other persistent headache disorders have
also shown response to various steroids. The case series on
post-infectious NDPH of shorter duration (a few of them
had headache duration of \3 months at the time of
observation) have also shown response to intravenous
steroids [5].
Most of our patients who received steroid showed
moderate to marked response on headache. Although
headache management and treatment were not standardized
in the patients, a response to steroids may be indicative of
immunological/inﬂammatory mechanisms for the genera-
tion of headaches.
Evidence of infectious (or post-infectious) etiology
associated with a few diseases has been supported by
winter and spring peaks in presentation. There were limited
studies on the seasonal variation of headache disorders.
However, available data indicate increased frequency of
headache attacks in autumn–winter and least attacks in
summer [14, 15]. In one of the largest case series of NDPH,
September was the most common month of onset [16]. This
headache proﬁle matches with the seasonal variations of
infections, especially respiratory infection. Viral infection
is a common occurrence in the general population. A
latency period of \30 days has been suggested as a pos-
sible link between a febrile event and a post-infectious
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123entity [17]. All our cases have \30 days of latency.
Therefore, a possibility of causal link exists in our patients.
Pathogenesis
It is difﬁcult to speculate on the mechanisms of post-
infectious headache, as current knowledge of the patho-
physiology of even classical primary headache disorders is
limited. Acute onset of headache in our patients and in
patients with NDPH is highly suggestive of some etiology.
Abrupt transition of episodic migraine to chronic migraine
also suggests similar possibilities. Vanast [18], in 1987,
suggested autoimmune disorder with a persistent viral
trigger for chronic benign daily headache (NDPH). Tissue
speciﬁcity is a general feature of post-infectious immune-
mediated conditions [4]. Our case series and review of the
literature, especially Almazov and Brand [8] observations,
and Li and Rozen’s [9] case series, suggest that meningeal
involvement may the primary site for the generation of
post-infectious headache. Rozen-Swidan [19] demonstrated
high-proinﬂammatory cytokine (TNF-a) in CSF in patients
with NDPH and treatment refractory chronic migraine.
Serum proinﬂammatory cytokine level was normal and the
authors suggested CNS activation in these patients.
Meninges are a type of connective tissue membranes.
Another important connective tissue membrane in the body
is synovial membrane of the joints. Reactive arthritis (ReA)
is a post-infectious disease entity of synovium/joints. We
speculate that mechanisms responsible for the generation of
joint pain in ReA may be primary mechanisms for the
generation of headache in our patients and probably in a
subset of patients with NDPH. The course of ReA is com-
parable to that of NDPH: short or self-limiting form, con-
tinuous, and remitting form [20]. Although acute ReA may
be associated with low TNF-a, chronic ReA shows high
production of TNF-a (like NDPH) [21]. ReA is the persis-
tence of pathogenic organisms or its products in the joint/
synoviumleading tolocal immune response.We speculatea
local immune reaction in the meninges for the generation of
headache in our patients and a subset of NDPH. Therefore,
such headache could be termed as ‘Reactive Headache’.
The meninges are most often thought of as simply a
protective barrier between the CNS and the periphery.
However, recent observations suggest that cellular com-
position of meninges include a large number of immune
cells (such as ﬁbroblasts, macrophages, dendritic cells, and
mast cell) and each of which are capable of releasing
proinﬂammatory, neuroexcitatory mediators in response
to inﬂammatory/immunological challenges and meninges
may have a potential role in modulation or generation of
pain, as it is richly innervated by trigeminal nerves [22,
23]. The meninges have also been recently implicated in
pain processing even at spinal levels [22]. Recently,
Wieseler et al. [23] have shown facial allodynia following
supradural administration of both the inﬂammatory soup
(bradykinin, histamine, serotonin, and prostaglandin E2)
and the immunogenic stimulus (gp120) in awake and freely
moving rats. These observations were associated with
meningeal inﬂammation and activation of meningeal resi-
dent immune cells suggesting a role of immunological
mechanisms in induction of meninges-induced pain. The
high CSF proinﬂammatory cytokine (TNF-a) in Rozen–
Swidan observations [19] may be, at least partly, because
of meningeal involvement.
Our case series and review of the literature suggest that
headache may occur in temporal relation of a febrile ill-
ness. We included only those patients who had symptoms
free period between febrile illness and the development of
headache to differentiate such type of headache with
headache directly related to febrile illness. However, any
post-infectious illness may develop within 2 days after an
antigenic challenge and post-infectious process may start
within febrile periods. As noted above, ﬂu-like illness or
other febrile illnesses are the risk factors for the develop-
ment of NDPH and acute transition of episodic headaches
into chronic daily headache. We speculate that a subset of
patients in these groups may be because of post-infectious
mechanisms. We further speculate that if an infection (or
post-infectious process) can trigger chronic headaches
([3 months duration), there is a possibility to develop
NDPH-like headache (or daily headaches) for shorter
duration (sub-acute NDPH) with variable prognosis (some
as self-limiting condition and some turning into refractory
NDPH after 3 months).
Most post-infectious illness have better prognosis if
treated earlier [4]. Even the case series of post-infectious
NDPH of shorter duration have shown favorable response
to IV MPS [5]. Therefore, identiﬁcation of this group is
important as early interventions may prevent them from
being refractory, as chronic daily headaches have poor
prognosis. Besides it, a few percentage patients (up to one-
third) of most of the post-infectious diseases do not have
clinically evident antecedent infections during the prior
few weeks [4].
Taken together, our case series, association of infection
as an important factor for the generation of CHD, and our
speculation on possible pathogenesis for this association
suggest that a subset of patients with daily or near daily
headache may be because of post-infectious immune
pathology. Our observations suggest that a few of them
may not respond to usual therapies of headache and may
turn into CDH ([3 months), and early immunosuppressive
drugs (steroids) may be helpful in this group of patients.
Therefore, it is important to look for the potential cases of
NDPH and other CDH in early stage. As our observation is
retrospective, it must be substituted by future prospective
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123studies. We suggest prospective studies on patients with
daily or near daily headache of sub-acute onset for the risk
factors for the chroniﬁcation of headache with special
reference to post-infectious etiology (both clinical and
laboratory features). Epidemiological studies on headache
prevalence/incidence especially during outbreaks of vari-
ous infections, such as respiratory, gastrointestinal or other
infections may also be done to conﬁrm this association. If
we can identify microbial agents that trigger an autoim-
mune disease, it may be possible to treat and even prevent
the disease.
Limitations of our observations
It is a retrospective study and possibilities of unrecognized
selection bias and recall bias exist. Our observation did not
have large enough numbers to uncover true differences in
the two groups. All our patients gave history of antecedent
infections before the onset of headache. However, con-
ﬁrmed laboratory diagnosis was available in only ﬁve
patients. We do not have any serological evidence of
infections in most of the patients. In addition, headache
management and treatment were not standardized. Besides
these, we cannot rule out even the possibility of other cause
of headache (secondary), as full evaluation for secondary
headache was not done. Neuroimaging was not done in all
the patients. A few secondary headache disorders may
resolve even without treatment. Besides these, our obser-
vations cannot be generalized as our sample of patients
may not truly represent patients with new onset headaches
due to referral and other biases. Moreover, geographical
variation of infectious pathogens should also be taken into
consideration for such type of observations.
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